Lupin Ltd has received tentative approval from the FDA for its generic version of a combination HIV treatment.

The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, ...

Lupin receives tentative USFDA approval for its generic HIV treatment, combining Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The drug, equivalent to Janssen's Symtuza, has ...

Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

When Descovy is used to treat HIV, it’s taken with other HIV drugs. Using a combination of drugs makes HIV less able to develop resistance to the drugs. Before you take Descovy to help prevent ...

Truvada was also the overall highest-selling drug on the market for the treatment of HIV in 2006, with sales of approximately US$1.2 billion worldwide 1. The first cross-class combination NRTI ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, confirming phase 3 testing results. HIV causes immunosuppression because the ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...